Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Advaxis Inc
(NQ:
ADXS
)
0.6070
USD
-0.0380 (-5.89%)
Streaming Delayed Price
/ Updated:
4:57 PM EDT, Oct 22, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
679,100
Open
0.6410
Bid (Size)
0.6100 (40)
Ask (Size)
0.6300 (47)
Prev. Close
0.6450
Today's Range
0.6070 - 0.6550
52wk Range
0.6071 - 3.850
Shares Outstanding
52,621,490
Dividend Yield
N/A
Performance
YTD
-80.42%
-80.42%
1 Month
-34.17%
-34.17%
3 Month
-61.82%
-61.82%
6 Month
-62.53%
-62.53%
1 Year
-82.66%
-82.66%
Top News
More News
Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of
October 18, 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Aethlon Medical, Inc....
Read More
from
GlobeNewswire News Releases
Advaxis to Present at the Cantor Fitzgerald Global Healthcare Conference
September 25, 2018
Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that Kenneth A. Berlin, President...
Read More
from
Business Wire News Releases
More News
Read More
Advaxis Announces Closing of Its Public Offering of Common Stock and Warrants
September 11, 2018
from
Business Wire News Releases
Advaxis Reports Fiscal 2018 Third Quarter Business Highlights and Financial Results
September 10, 2018
from
Business Wire News Releases
Advaxis Announces Pricing of Its Public Offering of Common Stock and Warrants
September 07, 2018
from
Business Wire News Releases
Advaxis, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants
September 06, 2018
from
Business Wire News Releases
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma
September 04, 2018
from
Business Wire News Releases
Mid-Afternoon Market Update: Okta Gains After Strong Q2 Results; eGain Shares Plummet
September 07, 2018
category
Commodities
,
News
,
Benzinga
, and 14 more.
from
Benzinga
Mid-Day Market Update: Dow Falls 150 Points; Dicerna Pharmaceuticals Shares Spike Higher
September 07, 2018
category
Market News
,
Markets
,
MCFT
, and 15 more.
from
Benzinga
Recent 52-Week Low Surpassed in Shares of Advaxis Inc (ADXS)
September 07, 2018
from
Comtex SmarTrend® News Briefs
Investors look to Lighten Up on Shares of Advaxis Inc, Shares Down 30.1% (ADXS)
September 07, 2018
from
Comtex SmarTrend® News Briefs
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
